Maxalt-mlt
Product Images NDC 54868-4499
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Maxalt-mlt (NDC 54868-4499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (Maxalt-MLT Tablets)
This appears to be a product information label which includes details about the distribution and identification of a medical product. The product is distributed by "Prysicians Total Care" and has an NDC code of 54868-4499-0. The label also includes a product identification code "HARALT-HLT 164G", a lot number, and an expiration date (whose format looks incorrect). There is also an "R" symbol, which typically indicates a trademark registration. The label ends with a series of numbers that could possibly be a product quantity or a further identification number.*
Image Of Rizatriptan Benzoate Chemical Structure (Maxalt 01)
Image Of Figure 1 (Maxalt 02)
Image Of Figure 2 (Maxalt 03)
This appears to be a graph showing the estimated probability of remediating or rescuing a certain situation or system. The graph uses percentages and appears to have several data points along a time axis. Without additional context or labels, it is difficult to determine the exact meaning or significance of the data.*
Image Of Figure 3 (Maxalt 04)
Image Of Figure 4 (Maxalt 05)
This text appears to be a graph or chart showing the Estimated Probability of Remediation or Rescue for a medication called MAXALT-MLT. It shows the probability percentages over a certain period of time (10-24 hours post-dose) and features two dosage options (MAXALT-MLTS mg and MAXALT-MLT 10 mg). Additionally, there is a photo included, though its subject is unknown without context.*
Image Of Figure 5 (Maxalt 06)
The text appears to be a table showing the percentage value with a confidence level of 95% for two conditions (MAXALTMLT and Placeho) at different time intervals (0, 10, 15, and 20 hours after the Stage 2 Dose). However, without the context and information about what condition or treatment is being studied, it is not possible to provide a more specific description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.